Sollinda Capital Management LLC Buys Shares of 2,677 SPDR S&P Biotech ETF (NYSEARCA:XBI)

Sollinda Capital Management LLC purchased a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) during the 4th quarter, HoldingsChannel reports. The institutional investor purchased 2,677 shares of the exchange traded fund’s stock, valued at approximately $239,000. Several other hedge funds have also recently bought and sold shares of the company. BOCHK Asset […]

Related Keywords

United States ,American , ,Company Profile ,National Market ,Wetzel Investment Advisors Inc ,National Association Of Securities Dealers Automated Quotation ,York Stock Exchange ,Wealth Management ,Concourse Financial Group Securities Inc ,New York Stock Exchange ,Nasdaq ,Asset Management Ltd ,Sollinda Capital Management ,American Stock Exchange ,Free Report ,Management Ltd ,Valley Asset Management Partners ,Investment Advisors ,Concourse Financial Group Securities ,Financial Group Securities ,National Association ,Securities Dealers Automated Quotation ,Visit Holdingschannel ,